"We really appreciate how quickly you were able to execute the agreements to start our trial. Your team has been outstanding and and very responsive. Nothing but compliments from CTI."
Timothy
J. Schroeder
President & CEO
CTI Clinical Trial & Consulting Services
"We chose Australia as the location for our first in human study based on considerations of quality, subject availability, shared culture and cost. However, as a small California company with less than 40 employees, we were concerned about the feasibility of an international clinical trial. CNS and their Phase 1 partners were highly responsive to our needs. An effective relationship soon developed which led to high quality and rapid implementation of the project in Australia ."
Patricia A Walicke
Vice President Clinical and Regulatory Affairs
Avidia, Inc.
“During my career I have worked with many clinical sites and CROs, but I can unequivocally state that I have never had a more positive experience than I have had with your organization.”
Mark Roffman,
PhD
VP Clinical and Regulatory Affairs
Agile Therapeutics Inc.
"I didn’t find the distance from the United States to be a problem. One of the advantages to Agile Therapeutics was that the per patient cost was slightly lower than the cost in the United States and was significantly lower when the currency difference was taken into consideration."
Thomas Stagnaro
President
Agile Therapeutics, Inc